U.S. Transportation Stock News

In late June 2026, 10x Genomics, Inc. was removed from several Russell value benchmarks, including the Russell 2000 Value and Russell 3000 Value indexes. This broad index exclusion can matter for investors because it often triggers selling by index-tracking funds, altering trading flows without any direct change to the company’s operations. We’ll explore how 10x Genomics’ removal from multiple Russell value indexes may influence its existing investment narrative built around product...

DICK'S Sporting Goods (DKS) refreshed its ScoreCard loyalty program, introducing ScoreCard+, a US$99 per year paid tier that offers free standard shipping, quarterly rewards, service discounts, and targeted perks tied to owned brands and its credit card. See our latest analysis for DICK'S Sporting Goods. At a share price of US$236.18, DICK'S Sporting Goods has a 30 day share price return of 9.94% and a 90 day share price return of 18.29%. Its 5 year total shareholder return of 171.99% points...

Capri Holdings Limited was recently reclassified within several Russell indices, added to multiple growth benchmarks and removed from value benchmarks, while also amending its revolving credit facility by reducing total commitments to US$1.00 billion and extending maturity to June 24, 2031. This shift from value to growth indices, combined with a longer-dated, multi-currency secured credit line, highlights how investors and lenders are reassessing Capri’s profile across style factors and...

Earlier this week, Donaldson Company reported fiscal 2026 third-quarter results with adjusted earnings and revenue exceeding analyst estimates and rising from a year ago, while guiding for full-year adjusted EPS of $3.94–$4.01 and organic sales growth of 3–5% across its segments. A key takeaway for investors is the especially strong outlook for the higher-growth Life Sciences segment, where management is targeting 9–11% sales growth, potentially shifting the company’s overall business mix...

In recent months, Entegris has drawn fresh attention as a key supplier of ultra-pure materials and filtration solutions for advanced nanochips used in AI and quantum computing, amid rising capital investment plans by major semiconductor manufacturers. This spotlight underscores how Entegris’ exposure to AI-related chip production and next-generation fabrication processes is increasingly central to its long-term business appeal. We’ll now examine how Entegris’ growing role in AI-related chip...

In Q1 2026, Nomad Foods reported a 5.9% year-over-year revenue decline and margin pressure tied to inventory and order realignment with retailers, but still exceeded analyst forecasts and kept its full-year guidance intact. An interesting angle is that, despite softer sales, Nomad Foods improved cash flow conversion and returned €45 million to shareholders through buybacks and dividends, underlining its focus on capital discipline. We’ll now explore how beating expectations while maintaining...

The live service model that once helped power hits like Destiny 2 is now under pressure, and that shift is rippling through gaming stocks. As Bungie, owned by Sony, pulls back on Destiny 2 updates and the industry leans toward blockbuster single player titles, investors are reassessing where future cash flows might come from. This article explains how that news connects to three stocks exposed to the same forces, highlighting one where the changing model could be a relative positive and two...

Amylyx Pharmaceuticals was removed in late June 2026 from multiple Russell equity indexes, while also reporting initial Phase 1 LUMINA data showing AMX0114 was generally well tolerated at the lowest dose in people living with ALS. The combination of broad index deletions and early but encouraging ALS safety data highlights how technical trading flows and pipeline progress can pull Amylyx’s story in different directions at the same time. Now we’ll examine how early Phase 1 LUMINA safety...

Gulfport Energy (GPOR) has just been added to the S&P Composite 1500 and S&P 600, while also joining multiple Russell value indices, a shift that can reshape how index funds trade the stock. See our latest analysis for Gulfport Energy. These index moves come after a mixed share price pattern for Gulfport Energy, with the stock up 2.09% over one day and 3.68% over seven days, but down 17.94% over three months and 18.09% year to date. The 5 year total shareholder return of 154.67% points to a...

Leadership change and record share price bring First Mid Bancshares into focus First Mid Bancshares (FMBH) is drawing investor attention after announcing that Matthew K. Smith will become Chief Executive Officer and President on July 1, 2026, and after its stock reached an all time high of $49.05. See our latest analysis for First Mid Bancshares. At a share price of $48.46, First Mid Bancshares has eased back slightly from its recent record but still reflects strong momentum, with a 30 day...

Mortgage lender stocks are in the spotlight again as markets react to a higher 27% implied chance of a Federal Reserve rate hike in July and fresh volatility in mortgage rates. For investors, the key question is which companies might benefit if borrowers rush to lock in current rates and near term mortgage demand pulls forward, and which could feel pressure from higher funding and credit costs. This article explains how that rate backdrop connects to mortgage lenders and highlights 3 stocks...

Hinge Health (HNGE) has been added to a wide range of Russell indexes, including the Russell 3000 and Russell 2000 families. This change may affect how many institutional investors gain exposure to the stock. See our latest analysis for Hinge Health. Recent trading shows strong momentum for Hinge Health, with a 30 day share price return of 32.11% and a 90 day share price return of 114.47%. The 1 year total shareholder return is 80.25%, suggesting sentiment has strengthened despite a 1 day...

Acuity Inc. (NYSE: AYI) recently reported its fiscal 2026 third-quarter results, showing year-over-year growth in sales, net income, and earnings per share, while maintaining its dividend and actively repurchasing shares under a long-running buyback program. Management also emphasized a disciplined approach to acquisitions to build out the Acuity Intelligence Spaces portfolio, prioritizing quality assets and balancing growth investments with continued shareholder returns. Now, we’ll explore...

The European Commission’s new antitrust investigation into Align Technology (ALGN), focused on its iTero scanners and Invisalign ecosystem, has sharpened attention on the stock’s risk profile and how potential regulatory outcomes could affect investor sentiment. See our latest analysis for Align Technology. Against the backdrop of the European Commission probe, Align Technology’s recent share price performance has been relatively firm, with a 10.0% 1 month share price return and an 18.3% year...

Agilent Technologies (NYSE:A) has released an AI powered xCELLigence RTCA eSight AI software module for biopharma research. The upgrade is designed to automate and standardize cell imaging analysis workflows, which may help reduce manual steps and variability for researchers. The launch introduces AI driven experimental analysis tools that support high throughput drug discovery and related applications. Agilent Technologies enters this launch with its stock at $130.69 and a mixed recent...

Some of the losses seen by insiders who purchased US$372.5k worth of Rapid7, Inc. ( NASDAQ:RPD ) shares over the past...

We'd be surprised if C3.ai, Inc. ( NYSE:AI ) shareholders haven't noticed that the President, Stephen Ehikian, recently...

EVERTEC stock reacts to strong cash generation and growth profile EVERTEC (EVTC) has drawn fresh investor attention after being highlighted as a significant cash producer with annual revenue and earnings growth above its peer group average, supported by a high return on equity. See our latest analysis for EVERTEC. At a share price of $29.63, EVERTEC has seen strong recent momentum, with a 30 day share price return of 32.63% and a 7 day share price return of 8.26%, even though the 1 year total...

Liquidia stock has turned into a very large five-year winner, yet the current valuation checks and premium pricing signal a stock that leans expensive rather than obviously cheap after such a run. Over five years, Liquidia has delivered roughly 29x returns, which puts extra focus on whether the current share price still offers a reasonable margin of safety. The commercial ramp of YUTREPIA and recent positive legal and clinical news can support high growth expectations, but the rich valuation...

Aerospace and defense stocks sit at the crossroads of global growth worries, shifting central bank paths, and ongoing geopolitical tension, which keeps security and high value industrial spending on many governments’ agendas. While inflation trends, energy prices, and trade pressures pull markets in different directions, this theme focuses on companies that manufacture aircraft, space systems, and defense equipment, or provide critical services to those activities. For investors looking for...

O'Reilly Automotive (NasdaqGS:ORLY) has reportedly made a cash offer to acquire Genuine Parts Company's auto parts division. The proposed deal is estimated at US$10b or more and would be O'Reilly's largest acquisition since 2008. Genuine Parts is weighing options that may include a spinoff or a sale to O'Reilly or another bidder. O'Reilly Automotive is a major US auto parts retailer serving both professional repair shops and do it yourself customers. The auto parts sector has been shaped by...

ADMA Biologics stock has delivered a very large 5 year gain, yet the broader valuation checks currently lean cheap, setting up a clear tension between past returns and what the market is asking investors to pay today. Over the past 5 years, ADMA Biologics has returned almost 7x, which puts extra focus on whether the current price still reflects a reasonable entry point after such a strong run. Potential margin expansion and progress on its hyperimmune globulin candidate for pneumococcal...

Heightened political tension around President Trump’s July 4 speech, visible partisan branding at the Freedom 250 events, and tighter security on the streets are all feeding into a broader debate about where risk, and potential opportunity, now sit in the market. Defense and security stocks are squarely in that conversation, as government priorities, protest activity, and even extreme weather can all shape budgets and sentiment. This article walks through 3 stocks from our Defense and...

VeriSign, Inc. recently completed a registered offering of US$550 million of 5.100% senior unsecured notes due 2031, issued under its existing indenture and featuring covenants on liens, sale-leasebacks, and change-of-control repurchase rights. This new debt financing framework, alongside flexible early redemption options, could influence how investors view VeriSign’s balance sheet resilience and capital allocation plans. We’ll now examine how this new 5.100% senior notes issuance might...